Norway
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 14.33 M
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
2 |
USD 11.06 M
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
3 |
USD 1.33 M
|
Dec. 31, 2023 | USD 0.19 | -0.80% |
|
Norway |
|
4 |
USD 913.21 K
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
|
5 |
USD 891.33 K
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
The Pharmaceuticals company in Norway with the highest Total Non-Current Liabilities is Photocure ASA (Oslo Stock Exchange: PHO.OL) at USD 14.33 M.
The Pharmaceuticals company in Norway with the lowest Total Non-Current Liabilities is Gentian Diagnostics ASA (Oslo Stock Exchange: GENT.OL) at USD 891.33 K.
The top 10 Pharmaceuticals companies in Norway by Total Non-Current Liabilities are Photocure ASA, Navamedic ASA, Ultimovacs ASA, Lifecare AS and Gentian Diagnostics ASA.
The bottom 10 Pharmaceuticals companies in Norway by Total Non-Current Liabilities are Gentian Diagnostics ASA, Lifecare AS, Ultimovacs ASA, Navamedic ASA and Photocure ASA.